"Phase 2 Study of Golidocitinib, a JAK1 Selective Inhibitor, As Maintenance Therapy in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy (JACKPOT26)"

作者全名："Jin, Jie; Cai, Qingqing; Zhang, Liling; Zou, Liqun; Li, Zengjun; Wu, Huijing; Zhou, Keshu; Qiu, Lihua; Su, Liping; Ding, Kaiyang; Zhou, Hui; Yu, Li; Li, Fei; Xiao, Qing; Li, Wenyu; Lin, Lie; Wang, Erhua; Chen, Lijia"

作者地址："[Jin, Jie] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Sch Med, Hangzhou, Peoples R China; [Cai, Qingqing] Sun Yat Sen Univ, Dept Med Oncol,Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Zhang, Liling] Wuhan Tongji Union Hosp, Dept Lymphoma, Wuhan, Peoples R China; [Zou, Liqun] Sichuan Univ, West China Hosp, Chengdu, Peoples R China; [Li, Zengjun] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Lymphoma & Hematol, Jinan, Peoples R China; [Wu, Huijing] Hubei Canc Ctr, Wuhan, Peoples R China; [Zhou, Keshu] Henan Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China; [Qiu, Lihua] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China; [Su, Liping] Shanxi Hosp Affiliated Canc, Shanxi Prov Canc Hosp, Taiyuan, Peoples R China; [Ding, Kaiyang] Anhui Prov Canc Hosp, Dept Hematol, Hefei, Peoples R China; [Zhou, Hui] Hunan Canc Hosp, Changsha, Peoples R China; [Yu, Li] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Li, Fei] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Chongqing, Peoples R China; [Li, Wenyu] Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China; [Lin, Lie] Hainan Med Univ, Hainan Gen Hosp, Hainan Affiliated Hosp, Haikou, Hainan, Peoples R China; [Wang, Erhua] Cent South Univ, Xiangya Hosp 3, Dept Hematol, Changsha, Peoples R China; [Chen, Lijia] Dizal Pharma, Shanghai, Peoples R China"

通信作者：　

来源：BLOOD

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001159740307176

JCR分区：Q1

影响因子：21

年份：2023

卷号：142

期号：　

开始页：　

结束页：　

文献类型：Meeting Abstract

关键词：　

摘要：　

基金机构：　

基金资助正文：